论文信息 - Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients - 字舞流文

Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients

I. Appollonio | L. Tremolizzo | C. Ferrarese | F. Piazza | V. Isella | E. Conti | Clara Zanchi | D. Cereda | G. Galimberti | A. Masetto | M. Casati | Alessandro Masetto